Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice.
B cells
CD20
Pneumocystis
Journal
mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533
Informations de publication
Date de publication:
05 05 2021
05 05 2021
Historique:
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
30
10
2021
Statut:
epublish
Résumé
Prior work has shown that parenterally administered anti-CD20 (5D2) inhibits CD4
Identifiants
pubmed: 33952667
pii: 6/3/e01144-20
doi: 10.1128/mSphere.01144-20
pmc: PMC8103991
pii:
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antigens, CD20
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI120033
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL139930
Pays : United States
Informations de copyright
Copyright © 2021 Dai et al.
Références
Transplant Proc. 2014 Oct;46(8):2908-11
pubmed: 25380948
Chest. 2014 Mar 1;145(3):663-664
pubmed: 24590034
mSphere. 2019 Sep 4;4(5):
pubmed: 31484742
Chest. 2013 Jul;144(1):258-265
pubmed: 23258406
JCI Insight. 2018 Jun 21;3(12):
pubmed: 29925696
J Immunol. 2015 Jul 15;195(2):611-20
pubmed: 26041535
FEMS Yeast Res. 2015 Sep;15(6):
pubmed: 26071598
Infect Immun. 2015 May;83(5):2043-52
pubmed: 25733518
Thromb Haemost. 2017 Jan 5;117(1):33-43
pubmed: 27683758
J Immunol. 2006 May 15;176(10):6147-54
pubmed: 16670323
J Neuroimmune Pharmacol. 2019 Dec;14(4):709-719
pubmed: 31435856